Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems

Katherine Sanchez, Robrina Walker, Aimee N C Campbell, Tracy L. Greer, Mei Chen Hu, Bruce D. Grannemann, Edward V. Nunes, Madhukar H. Trivedi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Comorbid psychiatric and substance use disorders are common and associated with poorer treatment engagement, retention, and outcomes. This study examines the presence of depressive symptoms and the demographic and clinical correlates in a diverse sample of substance abuse treatment seekers to better characterize patients with co-occurring depressive symptoms and substance use disorders and understand potential treatment needs. Methods: Baseline data from a randomized clinical effectiveness trial of a computer-assisted, Web-delivered psychosocial intervention were analyzed. Participants (N = 507) were recruited from 10 geographically diverse outpatient drug treatment programs. Assessments included the self-report Patient Health Questionnaire, and measures of coping strategies, social functioning, physical health status, and substance use. Results: One fifth (21%; n = 106) of the sample screened positive for depression; those screening positive for depression were significantly more likely to screen positive for anxiety (66.9%) and posttraumatic stress disorder (PTSD; 42.9%). After controlling for anxiety and PTSD symptoms, presence of depressive symptoms remained significantly associated with fewer coping strategies (P =.001), greater impairment in social adjustment (P <.001), and poorer health status (P <.001), but not to days of drug use in the last 90 days (P =.14). Conclusions: Depression is a clinically significant problem among substance abusers, and, in this study, patients who screened positive for depression were more likely to have co-occurring symptoms of anxiety and PTSD. Additionally, the presence of depressive symptoms was associated with fewer coping strategies and poorer social adjustment. Coping skills are a significant predictor of addiction outcomes, and it may be especially important to screen for and enhance coping among depressed patients. Evidence-based interventions that target coping skills and global functioning among substance abusers with depressive symptoms may be important adjuncts to usual treatment.

Original languageEnglish (US)
Pages (from-to)297-303
Number of pages7
JournalSubstance Abuse
Volume36
Issue number3
DOIs
StatePublished - Jul 3 2015

Fingerprint

Outpatients
Alcohols
Depression
Pharmaceutical Preparations
Post-Traumatic Stress Disorders
Substance-Related Disorders
Social Adjustment
Therapeutics
Anxiety
Psychological Adaptation
Health Status
Self Report
Psychiatry
Randomized Controlled Trials
Demography
Health

Keywords

  • addiction outcomes
  • coping strategies
  • Depression
  • substance use

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health

Cite this

Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems. / Sanchez, Katherine; Walker, Robrina; Campbell, Aimee N C; Greer, Tracy L.; Hu, Mei Chen; Grannemann, Bruce D.; Nunes, Edward V.; Trivedi, Madhukar H.

In: Substance Abuse, Vol. 36, No. 3, 03.07.2015, p. 297-303.

Research output: Contribution to journalArticle

Sanchez, Katherine ; Walker, Robrina ; Campbell, Aimee N C ; Greer, Tracy L. ; Hu, Mei Chen ; Grannemann, Bruce D. ; Nunes, Edward V. ; Trivedi, Madhukar H. / Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems. In: Substance Abuse. 2015 ; Vol. 36, No. 3. pp. 297-303.
@article{fd61a0af3b67448c962a6a8d48ea0c8a,
title = "Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems",
abstract = "Background: Comorbid psychiatric and substance use disorders are common and associated with poorer treatment engagement, retention, and outcomes. This study examines the presence of depressive symptoms and the demographic and clinical correlates in a diverse sample of substance abuse treatment seekers to better characterize patients with co-occurring depressive symptoms and substance use disorders and understand potential treatment needs. Methods: Baseline data from a randomized clinical effectiveness trial of a computer-assisted, Web-delivered psychosocial intervention were analyzed. Participants (N = 507) were recruited from 10 geographically diverse outpatient drug treatment programs. Assessments included the self-report Patient Health Questionnaire, and measures of coping strategies, social functioning, physical health status, and substance use. Results: One fifth (21{\%}; n = 106) of the sample screened positive for depression; those screening positive for depression were significantly more likely to screen positive for anxiety (66.9{\%}) and posttraumatic stress disorder (PTSD; 42.9{\%}). After controlling for anxiety and PTSD symptoms, presence of depressive symptoms remained significantly associated with fewer coping strategies (P =.001), greater impairment in social adjustment (P <.001), and poorer health status (P <.001), but not to days of drug use in the last 90 days (P =.14). Conclusions: Depression is a clinically significant problem among substance abusers, and, in this study, patients who screened positive for depression were more likely to have co-occurring symptoms of anxiety and PTSD. Additionally, the presence of depressive symptoms was associated with fewer coping strategies and poorer social adjustment. Coping skills are a significant predictor of addiction outcomes, and it may be especially important to screen for and enhance coping among depressed patients. Evidence-based interventions that target coping skills and global functioning among substance abusers with depressive symptoms may be important adjuncts to usual treatment.",
keywords = "addiction outcomes, coping strategies, Depression, substance use",
author = "Katherine Sanchez and Robrina Walker and Campbell, {Aimee N C} and Greer, {Tracy L.} and Hu, {Mei Chen} and Grannemann, {Bruce D.} and Nunes, {Edward V.} and Trivedi, {Madhukar H.}",
year = "2015",
month = "7",
day = "3",
doi = "10.1080/08897077.2014.937845",
language = "English (US)",
volume = "36",
pages = "297--303",
journal = "Substance Abuse",
issn = "0889-7077",
publisher = "Routledge",
number = "3",

}

TY - JOUR

T1 - Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems

AU - Sanchez, Katherine

AU - Walker, Robrina

AU - Campbell, Aimee N C

AU - Greer, Tracy L.

AU - Hu, Mei Chen

AU - Grannemann, Bruce D.

AU - Nunes, Edward V.

AU - Trivedi, Madhukar H.

PY - 2015/7/3

Y1 - 2015/7/3

N2 - Background: Comorbid psychiatric and substance use disorders are common and associated with poorer treatment engagement, retention, and outcomes. This study examines the presence of depressive symptoms and the demographic and clinical correlates in a diverse sample of substance abuse treatment seekers to better characterize patients with co-occurring depressive symptoms and substance use disorders and understand potential treatment needs. Methods: Baseline data from a randomized clinical effectiveness trial of a computer-assisted, Web-delivered psychosocial intervention were analyzed. Participants (N = 507) were recruited from 10 geographically diverse outpatient drug treatment programs. Assessments included the self-report Patient Health Questionnaire, and measures of coping strategies, social functioning, physical health status, and substance use. Results: One fifth (21%; n = 106) of the sample screened positive for depression; those screening positive for depression were significantly more likely to screen positive for anxiety (66.9%) and posttraumatic stress disorder (PTSD; 42.9%). After controlling for anxiety and PTSD symptoms, presence of depressive symptoms remained significantly associated with fewer coping strategies (P =.001), greater impairment in social adjustment (P <.001), and poorer health status (P <.001), but not to days of drug use in the last 90 days (P =.14). Conclusions: Depression is a clinically significant problem among substance abusers, and, in this study, patients who screened positive for depression were more likely to have co-occurring symptoms of anxiety and PTSD. Additionally, the presence of depressive symptoms was associated with fewer coping strategies and poorer social adjustment. Coping skills are a significant predictor of addiction outcomes, and it may be especially important to screen for and enhance coping among depressed patients. Evidence-based interventions that target coping skills and global functioning among substance abusers with depressive symptoms may be important adjuncts to usual treatment.

AB - Background: Comorbid psychiatric and substance use disorders are common and associated with poorer treatment engagement, retention, and outcomes. This study examines the presence of depressive symptoms and the demographic and clinical correlates in a diverse sample of substance abuse treatment seekers to better characterize patients with co-occurring depressive symptoms and substance use disorders and understand potential treatment needs. Methods: Baseline data from a randomized clinical effectiveness trial of a computer-assisted, Web-delivered psychosocial intervention were analyzed. Participants (N = 507) were recruited from 10 geographically diverse outpatient drug treatment programs. Assessments included the self-report Patient Health Questionnaire, and measures of coping strategies, social functioning, physical health status, and substance use. Results: One fifth (21%; n = 106) of the sample screened positive for depression; those screening positive for depression were significantly more likely to screen positive for anxiety (66.9%) and posttraumatic stress disorder (PTSD; 42.9%). After controlling for anxiety and PTSD symptoms, presence of depressive symptoms remained significantly associated with fewer coping strategies (P =.001), greater impairment in social adjustment (P <.001), and poorer health status (P <.001), but not to days of drug use in the last 90 days (P =.14). Conclusions: Depression is a clinically significant problem among substance abusers, and, in this study, patients who screened positive for depression were more likely to have co-occurring symptoms of anxiety and PTSD. Additionally, the presence of depressive symptoms was associated with fewer coping strategies and poorer social adjustment. Coping skills are a significant predictor of addiction outcomes, and it may be especially important to screen for and enhance coping among depressed patients. Evidence-based interventions that target coping skills and global functioning among substance abusers with depressive symptoms may be important adjuncts to usual treatment.

KW - addiction outcomes

KW - coping strategies

KW - Depression

KW - substance use

UR - http://www.scopus.com/inward/record.url?scp=84939470937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939470937&partnerID=8YFLogxK

U2 - 10.1080/08897077.2014.937845

DO - 10.1080/08897077.2014.937845

M3 - Article

VL - 36

SP - 297

EP - 303

JO - Substance Abuse

JF - Substance Abuse

SN - 0889-7077

IS - 3

ER -